In this study, silicon phthalocyanine dichloride (SiCl2Pc) was successfully encapsulated in β-cyclodextrin (β-CD) and hydroxy-propyl-β-cyclodextrin (HP-β-CD) using the kneading method. Dynamic Light Scattering (DLS) demonstrated complexes of various hydrodynamic diameters with moderate stability in aqueous solutions. Their structural characterization by Infrared Spectroscopy (FT- IR) indicated that a part of phthalocyanine is located inside the cyclodextrin cavity. Both photophysical and photochemical studies showed that phthalocyanine’s encapsulation in cyclodextrins increased its aqueous solubility. The photodynamic studies against A431 cancer cell line indicated that the complexes are more effective than pure SiCl2Pc. Pure SiCl2Pc’s photodynamic effect is characterized as dose-dependent, whereas both complexes presented a biphasic dose-response photodynamic effect. For the highest energy dose of 3.24 J/cm2, pure SiCl2Pc induced mild cell toxicity. SiCl2Pc-β-CD complex was the most promising photosensitizer, exhibiting the highest photodynamic effect when irradiated at 2.16 J/cm2.
GrzybowskiASakJPawlikowskiJ. A brief report on the history of phototherapy. Clin Dermatol2016; 34(5): 532–537. DOI: 10.1016/j.clindermatol.2016.05.002.
2.
AckroydRKeltyCBrownN, et al.The history of photodetection and photodynamic therapy. Photochem Photobiol2001; 74(5): 656–669. DOI: 10.1562/0031-8655(2001)074<0656:thopap>2.0.co.
3.
LiebertAKiatH. The history of light therapy in hospital physiotherapy and medicine with emphasis on Australia: evolution into novel areas of practice. Physiother Theory Pract2021; 37(3): 389–400. DOI: 10.1080/09593985.2021.1887060.
4.
YaqoobMDXuLLiC, et al.Targeting mitochondria for cancer photodynamic therapy. Photodiagnosis Photodyn Ther2022; 38: 102830. DOI: 10.1016/J.PDPDT.2022.102830.
5.
PintoMFerreiraCde LimaB, et al.Effects of 5-ALA mediated photodynamic therapy in oral cancer stem cells. J Photochem Photobiol, B2022; 235: 112552. DOI: 10.1016/J.JPHOTOBIOL.2022.112552.
6.
AdnaneFEl-ZayatEFahmyHM. The combinational application of photodynamic therapy and nanotechnology in skin cancer treatment: a review. Tissue Cell2022; 77: 101856. DOI: 10.1016/J.TICE.2022.101856.
7.
HatzKSchneiderUHenrichB, et al.Comparing ranibizumab monotherapy and combination with single photodynamic therapy in wet AMD: retreatment and morphologic results. Eur J Ophthalmol2017; 27(4): 470–475. DOI: 10.5301/ejo.5000886.
8.
GaoYYuTZhangY, et al.Anti-VEGF monotherapy versus photodynamic therapy and anti-vegf combination treatment for neovascular age-related macular degeneration: a meta-analysis. Invest Ophthalmol Vis Sci2018; 59(10): 4307–4317. DOI: 10.1167/iovs.17-23747.
9.
YoshidaMOishiAMiyakeM, et al.A Rescue photodynamic therapy for age-related macular degeneration refractory to anti-vascular endothelial growth factor monotherapy. Photodiagnosis Photodyn Ther2022; 38: 102745. DOI: 10.1016/J.PDPDT.2022.102745.
10.
WojewodaKGillstedtMToviJS, et al.Optimizing treatment of acne with photodynamic therapy (PDT) to achieve long-term remission and reduce side effects. A prospective randomized controlled trial. J Photochem Photobiol, B2021; 223: 112299. DOI: 10.1016/j.jphotobiol.2021.112299.
11.
WangYFuSLuY, et al.Chitosan/hyaluronan nanogels co-delivering methotrexate and 5-aminolevulinic acid: a combined chemo-photodynamic therapy for psoriasis. Carbohydr Polym2022; 277: 118819. DOI: 10.1016/j.carbpol.2021.118819.
12.
LinMHLeeJYYPanS, et al.Enhancing wound healing in recalcitrant leg ulcers with aminolevulinic acid-mediated antimicrobial photodynamic therapy. Photodiagnosis Photodyn Ther2021; 33: 102149. DOI: 10.1016/j.pdpdt.2020.102149.
13.
AgostinisPBergKCengelKA, et al.Photodynamic therapy of cancer: an update. CA A Cancer J Clin2011; 61(4): 250–281. DOI: 10.3322/caac.20114.
14.
Dos SantosAFDe AlmeidaDRQTerra, et al.Photodynamic therapy in cancer treatment - an update review. Journal of Cancer Metastasis and Treatment2019; 5(25). DOI: 10.20517/2394-4722.2018.83.
15.
AllenCMSharmanWMVan LierJE. Current status of phthalocyanines in the photodynamic therapy of cancer. J Porphyr Phthalocyanines2001; 05: 161–169. DOI: 10.1002/jpp.324.
16.
ClaessensCGHahnUTorresT. Phthalocyanines: from outstanding electronic properties to emerging applications. Chem Rec2008; 8(2): 75–97. DOI: 10.1002/tcr.20139.
17.
LoPCRodríguez-MorgadeMSPandeyRK, et al.The unique features and promises of phthalocyanines as advanced photosensitisers for photodynamic therapy of cancer. Chem Soc Rev2020; 49(4): 1041–1056. DOI: 10.1039/c9cs00129h.
18.
HalevasEArvanitidouMMavroidiB, et al.A novel curcumin gallium complex as photosensitizer in photodynamic therapy: synthesis, structural and physicochemical characterization, photophysical properties and in vitro studies against breast cancer cells. J Mol Struct2021; 1240: 130485. DOI: 10.1016/j.molstruc.2021.130485.
19.
SchmidtJKuzyniakWBerkholzJ, et al.Novel zinc- and silicon-phthalocyanines as photosensitizers for photodynamic therapy of cholangiocarcinoma. Int J Mol Med2018; 42(1): 534–546. DOI: 10.3892/ijmm.2018.3620.
ShangLZhouXZhangJ, et al.Metal nanoparticles for photodynamic therapy: a potential treatment for breast cancer. Molecules2021; 26(21): 6532. DOI: 10.3390/molecules26216532.
23.
BorzęckaWDomińskiAKowalczukM. Recent progress in phthalocyanine-polymeric nanoparticle delivery systems for cancer photodynamic therapy. Nanomaterials2021; 11(9): 2426. DOI: 10.3390/nano11092426.
24.
ZhangWLiJZhangW, et al.Novel phthalocyanine and PEG-methacrylates based temperature-responsive polymers for targeted photodynamic therapy. Polym Chem2013; 4(3): 782–788. DOI: 10.1039/c2py20668d.
25.
LiuJLiJZhangZ, et al.Encapsulation of hydrophobic phthalocyanine with poly(N-isopropylacrylamide)/lipid composite microspheres for thermo-responsive release and photodynamic therapy. Materials2014; 7(5): 3481–3493. DOI: 10.3390/ma7053481.
26.
DiasLMSharifiFde KeijzerMJ, et al.Attritional evaluation of lipophilic and hydrophilic metallated phthalocyanines for oncological photodynamic therapy. J Photochem Photobiol, B2021; 216: 112146. DOI: 10.1016/j.jphotobiol.2021.112146.
27.
MelloVCAraújoVHSde PaivaKLR, et al.Development of new natural lipid-based nanoparticles loaded with aluminum-phthalocyanine for photodynamic therapy against melanoma. Nanomaterials2022; 12(20): 3547. DOI: 10.3390/nano12203547.
28.
Ben MihoubALarueLMoussaronA, et al.Use of cyclodextrins in anticancer photodynamic therapy treatment. Molecules2018; 23(8): 1936. DOI: 10.3390/molecules23081936.
29.
KavetsouETsoukalas-KoulasCKatopodiA, et al.Ιnclusion complexes of magnesium phthalocyanine with cyclodextrins as potential photosensitizing agents. Bioengineering2023; 10(2): 244. DOI: 10.3390/bioengineering10020244.
30.
CarneiroSBDuarteFICHeimfarthL, et al.Cyclodextrin-drug inclusion complexes: in vivo and in vitro approaches. Int J Mol Sci2019; 20(3). DOI: 10.3390/ijms20030642.
31.
Cid-SamamedARakmaiJMejutoJC, et al.Cyclodextrins inclusion complex: preparation methods, analytical techniques and food industry applications. Food Chem2022; 384: 132467. DOI: 10.1016/j.foodchem.2022.132467.
32.
KotroniaMKavetsouELoupassakiS, et al.Encapsulation of oregano (origanum onites L.) essential oil in β-cyclodextrin (β-CD): synthesis and characterization of the inclusion complexes. Bioengineering2017; 4(3): 74. DOI: 10.3390/bioengineering4030074.
33.
GidwaniBVyasA. A comprehensive review on cyclodextrin-based carriers for delivery of chemotherapeutic cytotoxic anticancer drugs. BioMed Res Int2015; 2015: 198268. DOI: 10.1155/2015/198268.
34.
AdjaliAPontilloARNKavetsouE, et al.Clove essential oil–hydroxypropyl-β-cyclodextrin inclusion complexes: preparation, characterization and incorporation in biodegradable chitosan films. Micro2022; 2(1): 212–224. DOI: 10.3390/micro2010014.
35.
HalahlahAKavetsouEPitterouI, et al.Synthesis and characterization of inclusion complexes of rosemary essential oil with various β-cyclodextrins and evaluation of their antibacterial activity against Staphylococcus aureus. J Drug Deliv Sci Technol2021; 65: 102660. DOI: 10.1016/j.jddst.2021.102660.
36.
GiannakopoulosEKatopodiARallisM, et al.The effects of low power laser light at 661 nm on wound healing in a scratch assay fibroblast model. Laser Med Sci2023; 38(1): 27. DOI: 10.1007/s10103-022-03670-5.
37.
El-NahassMMAbd-El-RahmanKFAl-GhamdiAA, et al.Optical properties of thermally evaporated tin-phthalocyanine dichloride thin films, SnPcCl2. Phys B Condens Matter2004; 344(1–4): 398–406. DOI: 10.1016/j.physb.2003.10.019.
38.
SeoudiREl-BahyGSEl SayedZA. FTIR, TGA and DC electrical conductivity studies of phthalocyanine and its complexes. J Mol Struct2005; 753(1–3): 119–126. DOI: 10.1016/j.molstruc.2005.06.003.
39.
GómezARSánchez-HernándezCMFleitman-LevinI, et al.Optical absorption and visible photoluminescence from thin films of silicon phthalocyanine derivatives. Materials2014; 7(9): 6585–6603. DOI: 10.3390/ma7096585.
40.
KobayasriTKurokawaFUyedaN, et al.The metal-ligand vibrations in the infrared spectra of various metal phthalocyanines. Spectrochimica Apta1970; 26: 1305–1311. DOI: 10.1016/0584-8539(70)80036-8.
41.
RachmawatiHEdityaningrumCAMauludinR. Molecular inclusion complex of curcumin-β-cyclodextrin nanoparticle to enhance curcumin skin permeability from hydrophilic matrix gel. AAPS PharmSciTech2013; 14(4): 1303–1312. DOI: 10.1208/s12249-013-0023-5.
42.
SaokhamPMuankaewCJansookP, et al.Solubility of cyclodextrins and drug/cyclodextrin complexes. Molecules2018; 23(5): 1161. DOI: 10.3390/molecules23051161.
43.
CheirsilpBRakmaiJ. Inclusion complex formation of cyclodextrin with its guest and their applications. Biol Eng Med2017; 2(1). DOI: 10.15761/bem.1000108.
44.
ZhouJJiaJHeJ, et al.Cyclodextrin inclusion complexes and their application in food safety analysis: recent developments and future prospects. Foods2022; 11(23): 3871. DOI: 10.3390/foods11233871.
45.
da Silva JúniorWFde Oliveira PinheiroJGMoreiraC, et al.Alternative technologies to improve solubility and stability of poorly water-soluble drugs. Biosensing and Diagnostics2017; 281–305: 281–305. DOI: 10.1016/B978-0-323-52725-5.00015-0.
ShendePKGaudRSBakalR, et al.Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies. Colloids Surf B Biointerfaces2015; 136: 105–110. DOI: 10.1016/j.colsurfb.2015.09.002.
48.
TaoFHillLEPengY, et al.Synthesis and characterization of β-cyclodextrin inclusion complexes of thymol and thyme oil for antimicrobial delivery applications. LWT - Food Sci Technol (Lebensmittel-Wissenschaft -Technol)2014; 59(1): 247–255. DOI: 10.1016/j.lwt.2014.05.037.
49.
HadianZMalekiMAbdiK, et al.Preparation and characterization of nanoparticle β-cyclodextrin: geraniol inclusion complexes. Iran J Pharm Res (IJPR)2018; 17(1): 39–51. DOI: 10.22037/IJPR.2018.2153.
50.
DanaeiMDehghankholdMAtaeiS, et al.Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics2018; 10(2): 57. DOI: 10.3390/pharmaceutics10020057.
51.
ReisTAJaculiAERamosKLV, et al.Combination of cyclodextrin complexation and iontophoresis as a promising strategy for the cutaneous delivery of aluminum-chloride phthalocyanine in photodynamic therapy. Eur J Pharmaceut Sci2019; 139: 105056. DOI: 10.1016/j.ejps.2019.105056.
52.
MessnerMKurkovSJansookP, et al.Self-assembled cyclodextrin aggregates and nanoparticles. Int J Pharm2010; 387(1-2): 199–208.
53.
BhattacharjeeS. DLS and zeta potential - what they are and what they are not?J Contr Release2016; 235: 337–351. DOI: 10.1016/j.jconrel.2016.06.017.
54.
SilvaARASimioniARTedescoAC. Photophysical and complexation studies of chloro-aluminum phthalocyanine with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin. J Nanosci Nanotechnol2011; 11(5): 4046–4055. DOI: 10.1166/jnn.2011.3823.
55.
CoisneCTilloySMonflierE, et al.Cyclodextrins as emerging therapeutic tools in the treatment of cholesterol-associated vascular and neurodegenerative diseases. Molecules2016; 21: 1748. DOI: 10.3390/molecules21121748.
NkangaCIKrauseRWM. Encapsulation of isoniazid-conjugated phthalocyanine-in-cyclodextrin-in-liposomes using heating method. Sci Rep2019; 9(1): 11485. DOI: 10.1038/s41598-019-47991-y.
58.
JaymeCCCaloriIRTedescoAC. Spectroscopic analysis of aluminum chloride phthalocyanine in binary water/ethanol systems for the design of a new drug delivery system for photodynamic therapy cancer treatment. Spectrochim Acta Mol Biomol Spectrosc2016; 153: 178–183. DOI: 10.1016/j.saa.2015.08.027.
59.
DridiSKhiariJEMagnaG, et al.Synthesis and characterization of new-type soluble β-substituted zinc phthalocyanine derivative of clofoctol. Molecules2023; 28(10): 4102. DOI: 10.3390/molecules28104102.
60.
TauPOgunsipeAOMareeS, et al.Influence of cyclodextrins on the fluorescence, photostability and singlet oxygen quantum yields of zinc phthalocyanine and naphthalocyanine complexes. J Porphyr Phthalocyanines2003; 07: 439–446. DOI: 10.1142/S1088424603000562.
61.
BayrakRAkayHTPikinM, et al.Azine-bridged binuclear metallophthalocyanines functioning photophysical and photochemical-responsive. Dyes Pigments2012; 95(2): 330–337. DOI: 10.1016/j.dyepig.2012.05.010.
62.
Veprek-SiskaJSchwertnerovaEWagnerovaDM, et al.The aggregation and reaction with oxygen of the tetrasodium salt of cobalt phthalocyanine-4,4’,4”,4”’-tetrasulphonic acid. Aust J Chem1971; 26(2): 319–323. DOI: 10.1071/CH9730319.
63.
FengZTangTWuT, et al.Perfecting and extending the near-infrared imaging window. Light Sci Appl2021; 10(1): 197. DOI: 10.1038/s41377-021-00628-0.
64.
GhaniFKristenJRieglerH. Solubility properties of unsubstituted metal phthalocyanines in different types of solvents. J Chem Eng Data2012; 57(2): 439–449. DOI: 10.1021/je2010215.
65.
BoonyarattanakalinKViernsteinHWolschannP, et al.Influence of ethanol as a Co-Solvent in cyclodextrin inclusion complexation: a Molecular Dynamics Study. Sci Pharm2015; 83(2): 387–399. DOI: 10.3797/scipharm.1412-08.
66.
MosingerJKlimentVSejbalJ, et al.Host-guest complexes of anionic porphyrin sensitizers with cyclodextrins. J Porphyr Phthalocyanines2002; 06: 514–526. DOI: 10.1142/S1088424602000646.
67.
Bautista-SanchezAKasselouriADesrochesMC, et al.Photophysical properties of glucoconjugated chlorins and porphyrins and their associations with cyclodextrins. J Photochem Photobiol, B2005; 81(3): 154–162. DOI: 10.1016/j.jphotobiol.2005.05.013.
68.
GuoXAnWShuangS, et al. .Study on spectroscopic characterization of meso-tetrakis (4-hydroxyphenyl) porphyrin (THPP) in β-cyclodextrin and its derivatives. J Photochem Photobiol Chem2005; 173(3): 258–263. DOI: 10.1016/j.jphotochem.2005.04.004.
69.
ZhangGShuangSDongC, et al.Investigation on DNA assembly to neutral red-cyclodextrin complex by molecular spectroscopy. J Photochem Photobiol, B2004; 74(2–3): 127–134. DOI: 10.1016/j.jphotobiol.2004.03.006.
70.
KrawinkelJRichterUTorres-MapaML, et al.Optical and electron microscopy study of laser-based intracellular molecule delivery using peptide-conjugated photodispersible gold nanoparticle agglomerates. J Nanobiotechnol2016; 14(1): 2. DOI: 10.1186/s12951-015-0155-8.
71.
DongYZhouLShenZ, et al.Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy. Drug Deliv2022; 29(1): 238–253. DOI: 10.1080/10717544.2021.2023701.
72.
RusznyákÁPalicskóMMalangaM, et al.Cellular effects of cyclodextrins: studies on HeLa cells. Molecules2022; 27(5): 1589. DOI: 10.3390/molecules27051589.
73.
BarataJFBZamarrónANevesMGPMS, et al.Photodynamic effects induced by meso-tris(pentafluorophenyl)corrole and its cyclodextrin conjugates on cytoskeletal components of HeLa cells. Eur J Med Chem2015; 92: 135–144. DOI: 10.1016/j.ejmech.2014.12.025.
74.
Leroy-LechatFWouessidjeweDAndreuxJPJP, et al.Evaluation of the cytotoxicity of cyclodextrins and hydroxypropylated derivatives. Int J Pharm X1994; 101(1-2): 97–103. DOI: 10.1016/0378-5173(94)90080-9.
75.
LuSMaYJXuanHY, et al.A novel assembling complex of hydrobobic phthalocyanine-cyclodextrin: preparation, characterization, molecular modeling, and in vitro activity. RSC Adv2014; 4(104): 59759–59763. DOI: 10.1039/c4ra12654h.
76.
LuSWangAMaYJ, et al.Cyclodextrin type dependent host-guest interaction mode with phthalocyanine and their influence on photodynamic activity to cancer. Carbohydr Polym2016; 148: 236–242. DOI: 10.1016/j.carbpol.2016.04.062.
77.
LourençoLMOPereiraPMRMacielE, et al.Amphiphilic phthalocyanine-cyclodextrin conjugates for cancer photodynamic therapy. Chem Commun2014; 50(61): 8363–8366. DOI: 10.1039/c4cc02226b.
78.
TanakaMKinoshitaMYoshiharaY, et al.Photodynamic therapy using intra-articular photofrin for murine MRSA arthritis: biphasic light dose response for neutrophil-mediated antibacterial effect. Laser Surg Med2011; 43(3): 221–229. DOI: 10.1002/lsm.21037.
79.
KazantzisKTKoutsonikoliKMavroidiB, et al.Curcumin derivatives as photosensitizers in photodynamic therapy: photophysical properties and: in vitro studies with prostate cancer cells. Photochem Photobiol Sci2020; 19(2): 193–206. DOI: 10.1039/c9pp00375d.
80.
GunaydinGGedikMEAyanS. Photodynamic therapy—current limitations and novel approaches. Front Chem2021; 9: 691697. DOI: 10.3389/fchem.2021.691697.
81.
RodriguesJAAmorimRSilvaM, et al.Photodynamic therapy at low-light fluence rate: in vitro assays on colon cancer cells. IEEE J Sel Top Quant Electron2019; 25(1): 1–6. DOI: 10.1109/JSTQE.2018.2889426.
82.
PenjweiniRLoewHGEisenbauerM, et al.Modifying excitation light dose of novel photosensitizer PVP-Hypericin for photodynamic diagnosis and therapy. J Photochem Photobiol, B2013; 120: 120–129. DOI: 10.1016/j.jphotobiol.2012.12.013.
HussainZThuHEAmjadM, et al.Exploring recent developments to improve antioxidant, anti-inflammatory and antimicrobial efficacy of curcumin: a review of new trends and future perspectives. Mater Sci Eng C2017; 77: 1316–1326. DOI: 10.1016/j.msec.2017.03.226.
85.
JarviMTPattersonMSWilsonBC. Insights into photodynamic therapy dosimetry: simultaneous singlet oxygen luminescence and photosensitizer photobleaching measurements. Biophys J2012; 102(3): 661–671. DOI: 10.1016/j.bpj.2011.12.043.
86.
BarrHBoulosPBMacrobertAJ, et al.Comparison of lasers for photodynamic therapy with a phthalocyanine photosensitizer. Laser Med Sci1989; 4: 7–12.
